Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease.
暂无分享，去创建一个
Á. Valverde | A. Sabirsh | L. Jermutus | C. Rondinone | M. Coghlan | D. Baker | J. Mölne | M. Söderberg | Alison L. Bigley | B. Valastro | B. Santamaria | Marcela Herrera | S. Guionaud | S. Heasman | C. Quinn | C. M. Quinn